Lancaster General Ann B Barshinger Cancer Institute — Lancaster, Pennsylvania

Lancaster General Ann B Barshinger Cancer Institute is a clinical research site located in Lancaster, Pennsylvania, United States 17601.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

Lancaster General Ann B Barshinger Cancer Institute has participated in 20 clinical trials with 18 currently active.

Therapeutic areas: Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, NRG Oncology.

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lancaster General Ann B Barshinger Cancer Institute?

Lancaster General Ann B Barshinger Cancer Institute has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lancaster General Ann B Barshinger Cancer Institute conducted?

Lancaster General Ann B Barshinger Cancer Institute has 20 clinical trials on record, with 18 currently active. Their work covers Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8.

Is Lancaster General Ann B Barshinger Cancer Institute accredited by Crixeo Health?

Yes — Lancaster General Ann B Barshinger Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Lancaster General Ann B Barshinger Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.